The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation

Journal of Pathology

Volumn 213, Issue 1, 2007, Pages 106-115

  Jaye, D L ^a   Iqbal, J ^b   Fujita, N ^a   Geigerman, C M ^a   Li, S ^a   Karanam, S ^a   Fu, K ^b   Weisenburger, D D ^b   Chan, W C ^b   Moreno, C S ^a   Wade, P A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Gene expression profiling; Haematolymphoid organs; Immunostaining; Lymphoid neoplasms

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; METASTASIS ASSOCIATED PROTEIN MTA3; PROTEIN BCL 6; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GERMINAL CENTER; HUMAN; HUMAN TISSUE; LYMPHOID CELL; PLASMA CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

B-LYMPHOCYTES; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; GERMINAL CENTER; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-BCL-6; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 34548393739     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2199     Document Type: Article

References (49)

1. Esteller M. Dormant hypermethylated tumour suppressor genes: questions and answers. J Pathol 2005;205(2):172-180.
2. Bowen NJ, Fujita N, Kajita M, Wade PA. Mi-2-Nu,RD: multiple complexes for many purposes. Biochim Biophys Acta 2004; 1677(1-3):52-57.
3. Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodelling and histone deacetylase activities. Mol Cell 1998;2(6):851-861.
4. Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, Boss JM, et al. MTA3 and the Mi-2-NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 2004;119(1):75-86.
5. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000;13(2):199-212.
6. Shapiro-Shelef M, Lin KI, McHeyzer-Wilhams LJ, Liao J, McHeyzer-Williams MG, Calame K. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and preplasma memory B cells. Immunity 2003;19(4):607-620.
7. Staudt LM. Cancer: negative feedback for B cells. Nature 2004; 431(7011):919-920.
8. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997;16(2):161-170.
9. Wang X, Li Z, Naganuma A, Ye BH. Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc Natl Acad Sci USA 2002;99(23):15018-15023.
10. Artiga MJ, Saez AI, Romero C, Sanchez-Beato M, Mateo MS, Navas C, et al. A short mutational hot spot in the first intron of BCL-6 is associated with increased BCL-6 expression and with longer overall survival in large B cell lymphomas. Am J Pathol 2002; 160(4):1371-1380.
11. Cattoretti G, Pasqualucci L, Ballon G, Tam W, Nandula SV, Shen Q, et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 2005; 7(5):445-455.
12. Onizuka T, Moriyama M, Yamochi T, Kuroda T, Kazama A, Kanazawa N, et al. BCL-6 gene product, a 92- to 98-kD nuclear pbosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 1995;86(1):28-37.
13. Lossos IS, Levy R. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene. Blood 2000; 96(2):635-639.
14. Pasqualucci L, Bereschenko O, Niu H, Klein U, Basso K, Gugliehmino R, et al. Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. Leuk Lymphoma 2003;44(suppl 3):S5-12.
15. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA. MTA3, a Mi-2-NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003;113(2):207-219.
16. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B cell lymphoma. N Engl J Med 2002;346(25):1937-1947.
17. Jaffe ES, Harris NL, Stein H, Vardiman J. World Health Organization Classification of Tumours: Tumours of the Haemotopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001.
18. Storz MN, van de Rijn M, Kim YH, Mraz-Gernhard S, Hoppe RT, Kohler S. Gene expression profiles of cutaneous B cell lymphoma. J Invest Dermatol 2003;120(5):865-870.
19. Bohen SP, Troyanskaya OG, Alter O, Warnke R, Botstein D, Brown PO, et al. Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci USA 2003; 100(4):1926-1930.
20. de Hoon MJ, Imoto S, Nolan J, Miyano, S. Open source clustering software. Bioinformatics 2004;20(9):1453-1454.
21. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B cell lymphoma identified by gene expression profiling. Nature 2000;403(6769):503-511.
22. Shaffer AL, Rosenwald A, Hurt EM, Giltnane JM, Lam LT, Pickeral OK, et al. Signatures of the immune response. Immunity 2001; 15(3):375-385.
23. Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004; 432(7017):635-639.
24. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 2005;6(10):1054-1060.
25. Li Z, Wang X, Yu RY, Ding BB, Yu JJ, Dai XM, et al. BCL-6 negatively regulates expression of the NF-κBI p105/p5O subunit. J Immunol 2005;174(1):205-214.
26. Cossman J. Gene expression analysis of single neoplastic cells and the pathogenesis of Hodgkin's lymphoma. J Histochem Cytochem 2001; 49(6):799-800.
27. Hoefhagel JJ, Dijkman R, Basso K, Jansen PM, Hallermann C, Willemze R, et al. Distinct types of primary cutaneous large B cell lymphoma identified by gene expression profiling. Blood 2005; 105(9):3671-3678.
28. Muto A, Tashiro S, Nakajima O, Hoshino H, Takahashi S, Sakoda E, et al. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 2004; 429(6991):566-571.
29. Klein U, Tu Y, Stolovitzky GA, Keller JL, Haddad J Jr, Miljkovic V, et al. Transcriptional analysis of the B cell germinal center reaction. Proc Nail Acad Sci USA 2003;100(5):2639-2644.
30. Golay J, Broccoli V, Lamorte G, Bifulco C, Parravicini C, Pizzey A, et al. The A-Myb transcription factor is a marker of centroblasts in vivo. J Immunol 1998;160(6):2786-2793.
31. Pan Z, Shen Y, Du C, Zhou G, Rosenwald A, Staudt LM, et al. Two newly characterized germinal center B cell-associated genes, GCETI and GCE72, have differential expression in normal and neoplastic B cells. Am J Pathol 2003;163(l):135-144.
32. Calame KL, Lin KI, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003; 21:205-230.
33. Adams B, Dorfler P, Aguzzi A, Kozmik Z, Urbanek P, Maurer-Fogy I, et al. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev 1992;6(9):1589-1607.
34. Prescott JE, Osthus RC, Lee LA, Lewis BC, Shim H, Barrett JF, et al. A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation. J Biol Chem 2001;276(51):48276-48284.
35. Matoskova B, Wong WT, Nomura N, Robbins KC, Di Fiore PP. RN-tre specifically binds to the SH3 domain of eps8 with high affinity and confers growth advantage to NIH3T3 upon carboxy-terminal truncation. Oncogene 1996;12(12):2679-2688.
36. Shohat G, Spivak-Kroizinan T, Cohen 0, Bialik S, Shani G, Berrisi H, et al. The pro-apoptotic function of death-associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism. J Biol Chem 2001;276(50):47460-47467.
37. Galbiati F, Volonte D, Liu J, Capozza F, Frank PG, Zhu L, et al. Caveolin-I expression negatively regulates cell cycle progression by inducing G0/G1 arrest via a p53/p2l(WAFI/Cipl)-dependent mechanism. Mol Biol Cell 2001;12(8):2229-2244.
38. Heinrich R, Livne E, Ben-1zhak O, Aronheim A. The c-Jun dimerization protein 2 inhibits cell transformation and acts as a turnor suppressor gene. J Biol Chem 2004;279(7):5708-5715.
39. Miller TP, Grogan IM, Dahlberg S, Spier CM, Braziel RM, Banks PM, et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology group trial. Blood 1994;83(6):1460-1466.
40. Takeda N, Arima M, Tsuruoka N, Okada S, Hatano M, Sakamoto A, et al. Bc16 is a transcriptional repressor for the IL-18 gene. J Immunol 2003;171(1):426-431.
41. Toney LM, Cattoretti G, Graf JA, Merghoub T, Pandolfi PP, Dalla-Favera R, et al. BCL-6 regulates cbemokine gene transcription in macrophages. Nat Immunol 2000;1(3):214-220.
42. Tunyaplin C, Shaffer AL, Angelin-Duclos CD, Yu X, Staudt LM, Calame KL. Direct repression of prdml by Bcl-6 inhibits plasmacytic differentiation. J Immunol 2004;173(2):1158-1165.
43. Niu H, Cattoretti G, Dalla-Favera R. BCL6 controls the expression of the B7-11CD80 costimulatory receptor in germinal center B cells. J Exp Med 2003;198(2):211-221.
44. Harris MB, Chang CC, Berton MT, Danial NN, Zhang J, Kuehner D, et al, Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iε transcription and immunoglobulin E switching. Mol Cell Biol 1999; 19(10):7264-7275.
45. Baron BW, Anastasi J, Thirman MJ, Furukawa Y, Fears S, Kim DC, et al. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci USA 2002;99(5):2860-2865.
46. Hosokawa Y, Maeda Y, Seto M. Target genes downregulated by the BCL-6/ LAZ3 oncoprotein in mouse Ba/F3 cells. Biochem Biophys Res Commun 2001;283(3):563-568.
47. Ranuncolo SM, Polo JM, Dierov J, Shaknovich R, Carroll M, Melnick AM. BCL6 attenuates DNA damage sensing in normal and malignant B cells by directly repressing ATR. Blood 2005;106:157.
48. Tang TT, Dowbenko D, Jackson A, Toney L, Lewin DA, Dent AL, et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J Biol Chem 2002; 277(16):14255-14265.
49. Lin Y, Wong K, Calame K. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 1997; 276(5312):596-599.